Abate Kristin bought KPTI
January 27, 2026 · Form 4 insider transaction
Abate Kristin bought 92 shares of Karyopharm Therapeutics Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
92
Price
$0.00
Total value
N/A
InsiderAbate Kristin
RoleOfficer
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJanuary 27, 2026
Filing dateJanuary 29, 2026
Shares owned after22,672
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents the number of shares of the issuer's common stock underlying performance-based restricted stock units ("PSUs") granted in February 2023 that have been earned based on the level of achievement of the revenue and total shareholder return milestones as certified by the issuer's Compensation Committee on January 27, 2026. Each earned PSU represents the contingent right to receive one share of the issuer's common stock upon vesting. The earned PSUs vested on January 27, 2026.